Cargando…

Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy

Since the response to chemoradiotherapy in patients with locally advanced rectal cancer is heterogeneous, valid biomarkers are needed to monitor tumor response. Circulating microRNAs are promising candidates, however analyses of circulating microRNAs in rectal cancer are still rare. 111 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Peter, Azizian, Azadeh, Salendo, Junius, Kramer, Frank, Bernhardt, Markus, Wolff, Hendrik A., Gruber, Jens, Grade, Marian, Beißbarth, Tim, Ghadimi, B. Michael, Gaedcke, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485964/ https://www.ncbi.nlm.nih.gov/pubmed/28554991 http://dx.doi.org/10.3390/ijms18061140

Ejemplares similares

Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
por: Azizian, Azadeh, et al.
Publicado: (2016)

Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection
por: Bernhardt, Markus, et al.
Publicado: (2023)

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy
por: Emons, Georg, et al.
Publicado: (2022)

The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012)

KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
por: Jo, Peter, et al.
Publicado: (2020)

Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
por: Gaedcke, Jochen, et al.
Publicado: (2014)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Impact of RNA degradation on gene expression profiling
por: Opitz, Lennart, et al.
Publicado: (2010)

NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
por: Koerdel, Kristin, et al.
Publicado: (2021)

CA19-9 for detecting recurrence of pancreatic cancer
por: Azizian, Azadeh, et al.
Publicado: (2020)

STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2014)

A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells
por: Wolff, Alexander, et al.
Publicado: (2018)

Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
por: Flebbe, Hannah, et al.
Publicado: (2022)

Correction: A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells
por: Wolff, Alexander, et al.
Publicado: (2019)

Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019)

Incidence, Associated Risk Factors, and Outcomes of Postoperative Arrhythmia After Upper Gastrointestinal Surgery
por: Rühlmann, Felix, et al.
Publicado: (2022)

Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2021)

Incidence and impact of new-onset postoperative arrhythmia after surgery of the lower gastrointestinal tract
por: Rühlmann, Felix, et al.
Publicado: (2023)

UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib
por: Landmann, H, et al.
Publicado: (2014)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

Preoperative Chemoradiotherapy Does Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens—Results from a Prospective Evaluation with Extensive Pathological Work-up
por: Sprenger, Thilo, et al.
Publicado: (2009)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
por: Ghadimi, B. Michael, et al.
Publicado: (2006)

Pelvic intraoperative neuromonitoring during robotic-assisted low anterior resection for rectal cancer
por: Grade, Marian, et al.
Publicado: (2015)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Personalmanagement und Leadership in der Chirurgie
por: Grade, Marian, et al.
Publicado: (2021)

Acute burn care and outcomes at the Hospital Nacional Guido Valadares (HNGV), Timor-Leste: A 7-year retrospective study
por: Salendo, Junius, et al.
Publicado: (2022)

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
por: Gaedcke, J., et al.
Publicado: (2009)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
por: Leu, Martin, et al.
Publicado: (2021)

The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019)

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
por: Dröge, Leif Hendrik, et al.
Publicado: (2015)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Standard perioperative management in gastrointestinal surgery
por: Grade, Marian, et al.
Publicado: (2011)

The Impact of Molecular Pathology in Oncology: The Clinician’s Perspective
por: Grade, Marian, et al.
Publicado: (2004)

Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial
por: Diefenhardt, Markus, et al.
Publicado: (2022)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
por: Yaghobi Joybari, Ali, et al.
Publicado: (2021)

MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer
por: Du, Binbin, et al.
Publicado: (2018)

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
por: Machackova, Tana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_acg47776gppor450paktqupctm